Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer

Yinqi Gao; Xuelong Wang; Shihui Li; Zhiqiang Zhang; Xuefei Li; Fangcai Lin

doi:10.12659/MSM.930025

18 May 2021 : Database Analysis

Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer

Yinqi Gao^1ABCE, Xuelong Wang^2AC, Shihui Li^1CE, Zhiqiang Zhang^1CE, Xuefei Li^1CE, Fangcai Lin^1AE*

DOI: 10.12659/MSM.930025

Med Sci Monit 2021; 27:e930025

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 6 Methylation difference analysis of 5 differentially methylated sites within different risk groups in TCGA-TNBC (A), GSE141441 (B), and GSE78754 (C).

Back to the Article

Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer

Your Privacy